The product uses patented NOVEX-AMG zinc technology to provide 21-day protection against MRSA, C. diff, and SARS-CoV-2, targeting the $4.6B surface disinfectant market.
Alpha Score of 61 reflects moderate overall profile with strong momentum, weak value, strong quality, moderate sentiment.
Samaritan Shield Co. launched a national commercial rollout of a surface cleaner protectorant that bonds to surfaces and provides 21 days of protection from a single application. The Woodstock, Illinois-based company said the product uses patented NOVEX-AMG organometallic zinc technology to create a residual barrier that reduces pathogen load between cleaning cycles.
The launch targets the U.S. surface disinfectant market, valued at $4.6 billion in 2026 and growing at 8.2% annually, as demand shifts toward longer-lasting and sustainable formulations. Traditional disinfectants based on ethanol and quaternary ammonium compounds lose effectiveness once they dry, the company said.
"One application, three weeks of active defense, in a formula safe enough to use around patients, children, and food surfaces. The science backs every claim," Chief Executive Officer Rick Latella said in a statement.
Samaritan Shield is NSF Registered and Green Clean Institute Certified. The company said it is non-toxic and safe for food-adjacent surfaces, patients, children, and pets. The product is available in wipes, RTU spray, jugs, buckets, drums, and IBC totes. It works on granite, stainless steel, leather, upholstery, electronics, stone, and medical equipment.
Target markets include healthcare systems, long-term care facilities, contract cleaners, and other institutional buyers. The company is pursuing full EPA and PMRA registration.
The press release cited CDC data showing 1 in 31 hospital patients has a healthcare-associated infection on any given day, and WHO estimates 136 million antibiotic-resistant HAI cases globally each year. Samaritan Shield's product is designed to address infections including MRSA, C. difficile, and SARS-CoV-2.
Samaritan Shield was founded in 2020.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.